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Agenda
• Brief overview of the how the Joint Genome Institute 
came into existence.
• Overview of DNA sequencing production line at the 
JGI.
• How our throughput has increased since 1999 to 
become a high through-put sequencing facility.
• Some instrumentation improvement highlights along 
the way and how they are used.
• Review our approach to successful selection & 
implementation of new instruments to meet our 
needs.
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DOE JGI 
Production Genomics Facility
DOE JGI collaborates with DOE national laboratories and 
community users, to advance genome science in support of the 
DOE missions of clean bio-energy, carbon cycling, and 
bioremediation.
Opened in 1999
~240 UC Employees
60,000 sf
~$66M Annual Budget
Mission:
The DOE Joint Genome Institute 
(JGI) is a "virtual institute" that 
integrates the sequencing and 
analytical activities of six partner 
institutions: 
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Important Dates in DOE Genomics
• 1986 DOE announces Human Genome Initiative. 
With $5.3 million, pilot projects begin at DOE 
national laboratories to develop critical resources 
and technologies. 
• 1990 DOE & NIH present their joint HGP plan to 
Congress.  The 15-year project formally begins.
• 1997 DOE creates the JGI uniting activities at DOE 
human genome centers.
• 1999 JGI opens the Production Genomics Facility 
(PGF) in Walnut Creek, staff from LLNL & LBNL.
• 2000 HGP leaders & President Clinton announce the 
completion of a “working draft..the first great 
technological triumph of the 21st century.”
• 2003 HGP completed and published.
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What IS a Genome???
A GENOME is all of a living thing’s 
genetic material.  
The genetic material is DNA
(DeoxyriboNucleic Acid)
DNA, a double helical molecule,     
is made up of four nucleotide 
“letters”:
A-- G--
T-- C--
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JGI Production Mission
“Produce high quality cost efficient 
‘assemble-able’ sequence in a safe 
environment.”
FY 2006 Goals
• 52 million lanes = 35 billion bases
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How Sequencing is Done
Production Line Overview
• Library Creation
– Shearing the DNA (Genomic Solutions Hydroshear)
– Insertion of Fragments into Plasmid (Ligation)
– Transformation (Electroporation)
– Subcloning the Sheared Fragment (Plating)
– Colony Picking (Genetix QPix)
• Production Sequencing
– Lysing the Cell (Matrix PlateMate)
– Rolling Circle Amplification (MultiDrop Micro)
– Sequencing Chemistry (CyBio Vario)
– Post Sequencing Reaction Cleanup (BioMek FX)
– Capillary Sequencing (ABI 3730 & MB 4500)
• Assembly & QA
– Assembly (Phrap, JAZZ)
– Quality Assessment (Phred Q20)
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0.57 ¢.  
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DOE JGI 
Production Sequencing Efficiencies
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“Moore’s Law” of DNA Sequencing
• April 2002:  1 Gb/month
• January 2004:  2 Gb/month
• July 2004: 2.5 Gb/month
• March 2005: 3.1 Gb/month
(equivalent to 1 human genome/month)
Total (3/99-4/06)    114 Gb
(equivalent of sequencing 38 human genomes)
Main Production Metrics; Read Length & Pass Rate
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New Technologies Fuel Growth in 
Capacity and Reduce Costs
Capillaries
RCA
MB 4000
MB 4500
ABI3730XL
Fosmid Prep
454
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Capillary Sequencing
377
ABI
3730s
40001000
MegaBace 4500
7 days a week operation 400 plates/day
Qty 10; 2000 to 
Qty 84; 2002
Qty 28; 1997
Qty 5; 2001
Qty 35; 2002
Qty 55; 2003 Qty 70; 2004
Qty 36, upgraded 2004Qty 21; 2002 to Qty 36, 2003
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7yr Throughput Increases 
Correlated with # Sequencers
TOTAL, Sequencer Type
ABI
MB 20, MB1000s 84, MB1000s 21, MB4000s 35, MB4500s
5, ABI3730s 55, ABI3730s
36, MB4000s
70, ABI3730s35, ABI3730s28, ABI377s
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QPix2 (Qty 1; 2000, Qty 3; 2001, Qty4; 2002)
QPix2 XT
(Qty 1; 2004)
2nd Due 7/06
2 BioAssays & Stacked Dest Plates
96 pin picking head
Throughput (2 shifts = 16hrs)
~115 Bioassay Trays to produce 300 
(384 well) destination plates/day based 
on ~1000 colonies/tray
1999 Genomic Solutions & Hybaid Colony 
Pickers
Colony Picking
Agar Colonies on BioAssay Plates into 384 Destination Plates
OLD
NEW
Throughput ~Trays/day
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Hydra-Twister 
System
Cavro Syringe 
Pump Dispenser 
System
CyBi-Well Vario 
Integrated System
Qty 2; 2006
Sequence Chemistry
Aliquot RCA Product to Daughter Plates 
& Dispense FWD & REV Chemistry
Typical Aliquot 1.5uL RCA Product into 
two destination plates followed by 3.5uL 
Sequencing Chemistry Cocktail Dispense
Throughput (2 shifts = 16hrs)
6 batches, 42 source plates = 84 
destination plates
500+ plates/day
2.5hr/batch
21 source to 42 
destination ~1hr/batch
42 plates 
~40min/batch
OLD
NEW
Qty 2; 2001
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• In high throughput environment;
– automation does not necessarily increase productivity of workers,
– does increase repeatability
– increase equipment reliability
– frees up operator to perform other tasks
– reduce risk to operator of ergonomic issues
• “Islands of Automation”
– modular instruments with stacks of micro-titer plates transported 
& loaded by operators
• Semi-Automated Approach
– minimizes cost and maximizes flexibility
– compared to fully robotic systems
– presents a unique set of challenging issues when moving large 
volumes of plates
Why Automate?
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• Need to automate driven by;
– Lowering Reagent Volumes of expensive 
reagents <1uL & increments of 0.1uL
– Dilutions only go so far
– Wet & dry dispense
• 1536 not going to work in the near term
– sequencers in 384 format
– no thermal cycling
• Physical constraints of laboratory 
space, big issue currently (next slide)
Why Automate?
2006 Community 
Sequencing Program
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JGI Facility Layout
3730s
Production Support
3730s New Conference Center
Server room
Operations
Libraries RCA MegaBaces
Picking PCR
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• Performance
– Configuration, plate types (source & destination, 
conditioned (thermal cycled & incubated)), reagent types, 
throughput,  software compatibility, GUI ease of use, 
barcode scanning, ancillary services
– Error Rate (defining major & minor), how going to test 
stacker, pipettor, dispenser, barcode reader, tip wash.
– Measurement device, volumes, wet or dry dispense
– Safety – seismic restraint, ergonomics, hazards, “E” stop
– Integrated system test – method outline
– Operational testing
– Precision %CV, accuracy, reliability, ergonomic design
Approach to Automation Selection
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• Cost
– Expense warranted, efficient use of tax 
payer money
• Delivery
– time, how, installation, training
• Service
– field support, location of service 
engineers, response time, loaner parts, 
consumables supply
Approach to Automation Selection
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• Technology Transfer
– New or upgrading instrument technology
– Internal process improvements
– New processes introduced to production from R&D
• Performance
– Acceptance criteria
– Operational testing
• Duplicate partial batch
• Single production batch
• Statistical Analysis of Results
• Training
– SOP written during development phase, working draft
– Operator needs to know what to expect
Approach to Automation 
Implementation
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Summary
• Brief history of the Joint Genome Institute
• DNA sequencing production line
• Increased throughput since 1999
• Instrumentation improvement highlights
• Our approach to successful selection & 
implementation
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More Information?
More Information www.jgi.doe.gov
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• Martin Pollard, JGI Instrumentation Manager
• Susan Lucas, JGI Production Manager
• David Gilbert, JGI Public Relations Manager
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